Stocktoria

Kalaris Therapeutics, Inc. KLRS

Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-30

Kalaris Therapeutics, Inc. institutional holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC66,151$381,691
MILLENNIUM MANAGEMENT LLC59,534$343,511
TWO SIGMA INVESTMENTS, LP30,650$176,850

Source: SEC EDGAR filings · CIK 0001754068 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.